Interim PET/CT Guided Cycle Numbers of R-CHOP in Patients With Diffuse Large B-cell Lymphoma: a Exploratory Phase II Study Study
R-CHOP is the standard regimen for patients with diffuse large B-cell lymphoma (DLBCL).
However, the standard number of cycles is uncertain. Recently, interim PET/CT was found to
predict prognosis in DLBCL. The hypothesis of this study is to optimize the number of cycles
based on the interim results of PET/CT in order to avoid treatment exposure.
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
3-year progression-free survival
3 years
No
Ye Guo, MD
Principal Investigator
Fudan University
China: Ethics Committee
LMTG 13-01
NCT01804127
February 2013
December 2017
Name | Location |
---|